Retrospective analysis of lactic acidosis-related parameters upon and after metformin discontinuation in patients with diabetes and chronic kidney disease

No abstract is available for this paper.

• Publication year

  2016

• Venue

  International Urology and Nephrology

• Publication date

  2016-04-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11255-016-1288-xPMID 27102431
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metformin-associated lactic acidosis: Current perspectives on causes and risk.

  2016cited by this paper
• Adverse event notifications implicating metformin with lactic acidosis in Australia.

  2015cited by this paper
• Variations in Metformin Prescribing for Type 2 Diabetes

  2015cited by this paper
• Impact of Japanese regulatory action on metformin-associated lactic acidosis in type II diabetes patients

  2015cited by this paper
• Metformin-associated lactic acidosis: time to let it go?

  2015cited by this paper
• A justification for less restrictive guidelines on the use of metformin in stable chronic renal failure

  2014influential reference
• Metformin in patients with type 2 diabetes and kidney disease: a systematic review.

  2014cited by this paper
• Incidence of Lactic Acidosis in Patients With Type 2 Diabetes With and Without Renal Impairment Treated With Metformin: A Retrospective Cohort Study

  2014cited by this paper
• The enigma of metformin-associated lactic acidosis

  2014cited by this paper
• Population Pharmacokinetics of Metformin in Healthy Subjects and Patients with Type 2 Diabetes Mellitus: Simulation of Doses According to Renal Function

  2013cited by this paper
• Metformin therapy and kidney disease: a review of guidelines and proposals for metformin withdrawal around the world

  2013cited by this paper
• The criteria for metformin‐associated lactic acidosis: the quality of reporting in a large pharmacovigilance database

  2013cited by this paper
• Metformin revisited: a critical review of the benefit-risk balance in at-risk patients with type 2 diabetes.

  2013cited by this paper
• Erratum to: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  2013cited by this paper
• Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

  2012cited by this paper
• Diabetes, metformin and lactic acidosis

  2011cited by this paper
• Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements

  2011cited by this paper
• Metformin-associated lactic acidosis: is it really just an association?

  2011cited by this paper
• Metformin-Associated Acute Kidney Injury and Lactic Acidosis

  2011cited by this paper
• Comparative Effectiveness and Safety of Medications for Type 2 Diabetes: An Update Including New Drugs and 2-Drug Combinations

  2011cited by this paper
• Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

  2010cited by this paper
• Lactic Acidosis Induced by Metformin

  2010cited by this paper
• Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

  2010cited by this paper
• Metformin-associated lactic acidosis: A prognostic and therapeutic study*

  2009cited by this paper
• Prescribing metformin in type 2 diabetes with a contraindication: prevalence and outcome

  2009cited by this paper
• Metformin use in renal dysfunction: is a serum creatinine threshold appropriate?

  2009influential reference
• Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy

  2009cited by this paper
• Metformin, Sulfonylureas, or Other Antidiabetes Drugs and the Risk of Lactic Acidosis or Hypoglycemia

  2008cited by this paper
• Metformin-associated lactic acidosis in type 2 diabetes mellitus: incidence and presentation in common clinical practice.

  2008cited by this paper
• Metformin-associated lactic acidosis in an intensive care unit

  2008cited by this paper
• Metformin's contraindications should be contraindicated

  2005cited by this paper
• Lactic Acidosis: From Sour Milk to Septic Shock

  2005cited by this paper
• Comparative outcomes study of metformin intervention versus conventional approach the COSMIC Approach Study.

  2005cited by this paper
• Metformin and lactic acidosis: cause or coincidence? A review of case reports

  2004cited by this paper
• Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

  2003cited by this paper
• Measurement of metformin concentration in erythrocytes:clinical implications

  2003cited by this paper
• Contraindications to the use of metformin

  2003cited by this paper
• Metformin in patients with type 2 diabetes mellitus: reconsideration of traditional contraindications.

  2002cited by this paper
• Lactic acidosis in metformin therapy: searching for a link with metformin in reports of ‘metformin‐associated lactic acidosis’

  2001cited by this paper
• Contraindications to metformin therapy in patients with Type 2 diabetes—a population‐based study of adherence to prescribing guidelines

  2001cited by this paper
• The relationship between metformin therapy and the fasting plasma lactate in type 2 diabetes: The Fremantle Diabetes Study.

  2001cited by this paper
• A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

  1999cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Lactic acidosis in patients with diabetes treated with metformin.

  1998cited by this paper
• Definition of clinically relevant lactic acidosis in patients with internal diseases.

  1983cited by this paper

• Shouldn't Stage 4 And 5 Chronic Kidney Disease Patients Use Metformin?

  2022cites this paper
• Metformin use in patients with type 2 diabetes mellitus and chronic kidney disease: An evidence-based review.

  2021cites this paper
• Does metformin exposure before ICU stay have any impact on patients’ outcome? A retrospective cohort study of diabetic patients

  2017cites this paper
• Lactate Levels with Chronic Metformin Use: A Narrative Review

  2017cites this paper
• Safety of Metformin Therapy in Patients with Type 2 Diabetes Living on an Oxygen-Deficient Plateau, Tibet, China.

  2017cites this paper
• Laktatacidos i samband med metforminbehandling : Incidenstal och riskfaktorer

  2016cites this paper